Suppr超能文献

保留脾脏的改良D2根治性胃切除术与D2根治性胃切除术加脾切除术疗效的比较研究

[A comparative study on the efficacy of spleen-preserving modified D2 radical gastrectomy and D2 radical gastrectomy with splenectomy].

作者信息

Yao Xue-xin, Yan Chao, Yan Min, Li Chen, Chen Jun, Xiang Ming, Chen Ming-min, Zhu Zheng-gang, Yin Hao-ran, Lin Yan-zhen

机构信息

Department of General Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Feb;13(2):111-4.

Abstract

OBJECTIVE

To compare the efficacy of modified D(2) radical total gastrectomy with spleen-preserving and D(2) radical total gastrectomy with splenectomy in patients with gastric cancer located in the upper third, upper and middle third and entire stomach.

METHODS

One hundred and twelve patients with gastric cancer in the upper third, upper and middle third, or entire stomach underwent radical total gastrectomy between January 1989 and December 1994. Modified D(2) total radical gastrectomy with spleen-preserving (spleen-preservation group) was performed in 61 patients, and 51 underwent D(2) total radical gastrectomy with splenectomy (splenectomy group). The differences in clinicopathological characteristics,5-year survival rate, incidence of postoperative complication and hospital stay between the two groups were analyzed retrospectively.

RESULTS

There were no significant differences between the spleen-preservation group and the splenectomy group in gender, age, tumor size, T stage, N stage and TNM stage. The overall 5-year survival rate was 41.0% in the spleen-preservation group and 39.2% in the splenectomy group (P>0.05). The 5-year survival rates of patients with stage I, II, III and IIII were 100%, 66.7%, 27.8% and 17.4% in the spleen-preservation group, respectively, and were 100%, 70.0%, 26.7% and 5.6% in the splenectomy group, respectively (all P>0.05). The incidence of postoperative complication was lower in the spleen-preservation group (11.5% vs 27.5%, P<0.05). The mean hospital stay was longer in the splenectomy group (27.3 d vs 20.3 d, P=0.057).

CONCLUSION

The efficacy of modified D(2) radical total gastrectomy with spleen-preserving for patients with gastric cancer in the upper third, upper and middle third or entire stomach is similar to that of D(2) radical total gastrectomy with splenectomy, and the spleen-preserving procedure is associated with decreased postoperative complication and improved survival.

摘要

目的

比较保留脾脏的改良D(2)根治性全胃切除术与切除脾脏的D(2)根治性全胃切除术治疗胃上1/3、上中1/3及全胃胃癌患者的疗效。

方法

1989年1月至1994年12月期间,112例胃上1/3、上中1/3或全胃胃癌患者接受了根治性全胃切除术。61例患者接受了保留脾脏的改良D(2)根治性全胃切除术(保脾组),51例接受了切除脾脏的D(2)根治性全胃切除术(切脾组)。回顾性分析两组患者的临床病理特征、5年生存率、术后并发症发生率及住院时间的差异。

结果

保脾组与切脾组在性别、年龄、肿瘤大小、T分期、N分期及TNM分期方面无显著差异。保脾组总体5年生存率为41.0%,切脾组为39.2%(P>0.05)。保脾组Ⅰ、Ⅱ、Ⅲ和Ⅳ期患者的5年生存率分别为100%、66.7%、27.8%和17.4%,切脾组分别为100%、70.0%、26.7%和5.6%(均P>0.05)。保脾组术后并发症发生率较低(11.5%对27.5%,P<0.05)。切脾组平均住院时间较长(27.3天对20.3天,P=0.057)。

结论

保留脾脏的改良D(2)根治性全胃切除术治疗胃上1/3、上中1/3或全胃胃癌患者的疗效与切除脾脏的D(2)根治性全胃切除术相似,且保留脾脏手术可降低术后并发症发生率并改善生存情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验